FROM LEGACY TO INNOVATION: PIDOTIMOD’S EXPANDING THERAPEUTIC HORIZON: Pidotimod: Revisiting a Classic Immunomodulator. Mediterr J Hematol Infect Dis [Internet]. 2025 Aug. 31 [cited 2026 Jun. 9];17(1):e2025057. Available from: https://www.mjhid.org/mjhid/article/view/5993